Sanofi-Aventis unifies its generics business in Europe under Zentiva brand name
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis has announced the unification of its generic drugs business in Europe under Zentiva brand name. Zentiva is the Czech Republic's largest manufacturer of generic pharmaceuticals that Sanofi-Aventis acquired in a cash deal in 2009 after intensive negotiations with its shareholders (scripintelligence.com, 12 March 2009).